Showing results (21-30 of 127) with videos related to
Sort By:
Pageof 13
Plos One|May 10, 2013
In-vitro archaeacidal activity of biocides against human-associated archaeaSaber Khelaifia, Jean Michel Brunel, Jean Brunel Michel, et al.Antibiotics (Basel, Switzerland)|August 28, 2025
Efflux-Mediated Resistance in <i>Enterobacteriaceae</i>: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux PumpsFlorent Rouvier, Jean-Michel Brunel, Jean-Marie Pagès, et al.International Journal of Molecular Sciences|October 27, 2022
An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant StrainsAzza Troudi, Jean Michel Bolla, Naouel Klibi, et al.Biochimica Et Biophysica Acta. Biomembranes|August 10, 2025
Accurate antibiotic accumulation in Enterobacteriaceae isolates expressing efflux pumpsJinane Tabcheh, Julia Vergalli, Jean-Marie Pagès, et al.The Journal of Antimicrobial Chemotherapy|August 12, 2009
In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosisKamel Alhanout, Jean-Michel Brunel, Didier Raoult, et al.Journal of Medicinal Chemistry|August 26, 2020
New Polyaminoisoprenyl Antibiotics Enhancers against Two Multidrug-Resistant Gram-Negative Bacteria from <i>Enterobacter</i> and <i>Salmonella</i> SpeciesAurélie Lieutaud, Cyril Pieri, Jean Michel Bolla, et al.Frontiers in Microbiology|August 29, 2019
Polyamino-Isoprenyl Derivatives as Antibiotic Adjuvants and Motility Inhibitors for <i>Bordetella bronchiseptica</i> Porcine Pulmonary Infection TreatmentDiane Borselli, Jean Michel Brunel, Olivier Gorgé, et al.International Journal of Pharmaceutics|March 1, 2021
Feasibility of an inhaled antibiotic/adjuvant dry powder combination using an experimental design approachHana Douafer, Véronique Andrieu, Emmanuel Wafo, et al.European Journal of Medicinal Chemistry|December 2, 2004
Synthesis and antifungal activity of cholesterol-hydrazone derivativesCéline Loncle, Jean Michel Brunel, Nicolas Vidal, et al.Current Cancer Drug Targets|June 25, 2005
Squalamine: a polyvalent drug of the future?Jean Michel Brunel, Chanaz Salmi, Celine Loncle, et al.Pageof 13